Systemic level of IL-6 strongly correlates with obesity and insulin resistance and serum concentrations of IL-6, sIL-6R, and gp130 are elevated in patients with metabolic syndrome (MetS) and related cardiovascular disorders (77). Here, IL6 is linked to cardiovascular disorder.